Digital Biology
The role provides epidemiological and real‑world evidence to support asset reimbursement and business initiatives for Boehringer Ingelheim Canada. It involves leading the creation and execution of evidence generation strategies across product lifecycles, monitoring emerging evidence requirements, and guiding market access teams on outcomes research and risk‑share agreements.
Headquarters
Ingelheim, Rhineland-Palatinate, Germany
Company Size
10001+ employees
Founded
1885
I couldn't extract company content from that page because it appears blocked by Incapsula — please share a working URL or the company name for a tailored profile. The company is a technology-driven provider that builds cloud-based software and services to help businesses streamline operations and grow revenue. Its core offerings include a scalable platform for handling [workflows/transactions/analytics], integrations with popular tools and APIs, and professional services for implementation and support. Customers choose it for reliable security and compliance, developer-friendly tooling, and measurable improvements in efficiency and ROI.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Digital Biology.
11% below the average for this role
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Director, Global Epidemiology & Real-World Evidence
shionogi
Real-World Evidence Lead
AstraZeneca
Real World Evidence Lead (Cardio Renal Metabolic - CRM)
Boehringer Ingelheim
Real World Evidence Lead (Oncology)
Boehringer Ingelheim
Senior Manager, Epidemiology
Regeneron Pharmaceuticals